Product Data Sheet

eCF309

Catalog No. A79732

main product photo
eCF309 is a potent and selective mTOR inhibitor, exhibiting an IC50 of 15 nM. This compound demonstrates heightened selectivity over PI3 kinases, making it a valuable tool for research. eCF309 is particularly relevant in the study of breast cancer and prostate cancer, facilitating investigations into the mechanistic roles of mTOR signaling in these diseases.
Chemical Information
Catalog NumA79732
M. Wt383.40
FormulaC18H21N7O3
Purity>98%
Storageat -20 °C 3 years (powder form); at -20 °C 6 months (Solution base)
CAS No.2001571-40-8
Synonyms
SMILESNC1=C2C(N(CC(OCC)OCC)N=C2C3=CC=C(OC(N)=N4)C4=C3)=NC=N1
Biological Activity
DescriptioneCF309 is a potent and selective mTOR inhibitor, exhibiting an IC50 of 15 nM. This compound demonstrates heightened selectivity over PI3 kinases, making it a valuable tool for research. eCF309 is particularly relevant in the study of breast cancer and prostate cancer, facilitating investigations into the mechanistic roles of mTOR signaling in these diseases.
RETURN POLICY
Adooq’s Unconditional Return Policy ensures a smooth online shopping experience for our customers. If you are in any way unsatisfied with your purchase, you may return any item(s) within 7 days of receiving it. In the event of product quality issues, either protocol related or product related problems, you may return any item(s) within 365 days from the original purchase date. Please follow the instructions below when returning products.
SHIPPING AND STORAGE
Adooq products are transported at room temperature. If you receive the product at room temperature, please rest assured, the Adooq Quality Inspection Department has conducted experiments to verify that the normal temperature placement of one month will not affect the biological activity of powder products. After collecting, please store the product according to the requirements described in the datasheet. Most Adooq products are stable under the recommended conditions.